Literature DB >> 20484148

Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women.

Michael P Corcoran1, Mohsen Meydani, Alice H Lichtenstein, Ernst J Schaefer, Alice Dillard, Stefania Lamon-Fava.   

Abstract

Inflammation plays a central role in the development and progression of coronary heart disease (CHD). The sex hormones estrogen and testosterone have been shown to modify the inflammatory response by influencing cytokine expression in human macrophages obtained from younger individuals. The effect of these hormones on the expression of proinflammatory markers in macrophages obtained from a CHD age-relevant population has not been studied. Human monocyte-derived macrophages (HMDMs) were obtained from healthy normolipidemic men and postmenopausal women (age 50-70 years), and cultured in autologous serum along with both physiological and supraphysiological concentrations of estrogen or testosterone. HMDMs were stimulated with oxidized low-density lipoproteins, and the expression of the cytokines tumor necrosis factor alpha (TNF-alpha or TNF), interleukin (IL)6, and IL-1 beta (IL1B) and of the acute-phase protein C-reactive protein (CRP) was measured. Both physiological and supraphysiological concentrations of testosterone reduced the expression and secretion of TNF-alpha and reduced the expression of IL-1 beta, but did not affect the expression of IL6 or CRP. Estrogen did not modify the expression of TNF-alpha, IL6, and IL-1 beta. Estrogen caused a variable response in CRP expression that was positively associated with the plasma small dense LDL-cholesterol concentration of the donors. There were no gender differences in any of the observed effects. Our results indicate that testosterone may exert anti-inflammatory effects by reducing macrophage TNF-alpha expression, while the effects of estrogen on macrophage CRP expression may depend upon the extracellular lipid environment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484148      PMCID: PMC2954460          DOI: 10.1677/JOE-10-0057

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  47 in total

1.  The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism.

Authors:  Z Yesilova; M Ozata; I H Kocar; M Turan; A Pekel; A Sengul; I C Ozdemír
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

2.  Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells.

Authors:  Giuseppe Danilo Norata; Sara Raselli; Liliana Grigore; Katia Garlaschelli; Daniela Vianello; Sandra Bertocco; Alberto Zambon; Alberico Luigi Catapano
Journal:  Atherosclerosis       Date:  2009-03-25       Impact factor: 5.162

3.  Generation of C-reactive protein and complement components in atherosclerotic plaques.

Authors:  K Yasojima; C Schwab; E G McGeer; P L McGeer
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease.

Authors:  David M Herrington; Timothy D Howard; Gregory A Hawkins; David M Reboussin; Jianfeng Xu; Siqun L Zheng; K Bridget Brosnihan; Deborah A Meyers; Eugene R Bleecker
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

5.  Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells.

Authors:  Haruhiko Hatakeyama; Makoto Nishizawa; Atsushi Nakagawa; Shigeru Nakano; Toshikazu Kigoshi; Kenzo Uchida
Journal:  FEBS Lett       Date:  2002-10-23       Impact factor: 4.124

6.  17alpha-methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture.

Authors:  G Mor; M Eliza; J Song; B Wiita; S Chen; F Naftolin
Journal:  J Steroid Biochem Mol Biol       Date:  2001-12       Impact factor: 4.292

7.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong
Journal:  Circulation       Date:  2009-01-27       Impact factor: 29.690

8.  Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study.

Authors:  A Elisabeth Hak; Jacqueline C M Witteman; Frank H de Jong; Mirjam I Geerlings; Albert Hofman; Huibert A P Pols
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

9.  Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway.

Authors:  Bertrand Calippe; Victorine Douin-Echinard; Muriel Laffargue; Henrik Laurell; Vanessa Rana-Poussine; Bernard Pipy; Jean-Charles Guéry; Francis Bayard; Jean-François Arnal; Pierre Gourdy
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

10.  Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

Authors:  Aruna D Pradhan; JoAnn E Manson; Jacques E Rossouw; David S Siscovick; Charles P Mouton; Nader Rifai; Robert B Wallace; Rebecca D Jackson; Mary B Pettinger; Paul M Ridker
Journal:  JAMA       Date:  2002-08-28       Impact factor: 56.272

View more
  43 in total

Review 1.  Estrogen signaling and cardiovascular disease.

Authors:  Elizabeth Murphy
Journal:  Circ Res       Date:  2011-09-02       Impact factor: 17.367

Review 2.  Sex-based differences in immune function and responses to vaccination.

Authors:  Sabra L Klein; Ian Marriott; Eleanor N Fish
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01       Impact factor: 2.184

Review 3.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

4.  Immune signaling mechanisms of PTSD risk and symptom development: insights from animal models.

Authors:  Jessica Deslauriers; Susan Powell; Victoria B Risbrough
Journal:  Curr Opin Behav Sci       Date:  2017-04

5.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial.

Authors:  Grace Huang; Elizabeth Tang; Adam Aakil; Stephan Anderson; Hernan Jara; Maithili Davda; Helene Stroh; Thomas G Travison; Shalender Bhasin; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2014-04-08       Impact factor: 5.958

7.  Pubertal Status and Age are Differentially Associated with Inflammatory Biomarkers in Female and Male Adolescents.

Authors:  Allison Stumper; Daniel P Moriarity; Christopher L Coe; Lauren M Ellman; Lyn Y Abramson; Lauren B Alloy
Journal:  J Youth Adolesc       Date:  2019-08-13

Review 8.  Interactions between age, sex, and hormones in experimental ischemic stroke.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Neurochem Int       Date:  2012-10-13       Impact factor: 3.921

Review 9.  Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?

Authors:  Piotr Zareba; Wilhelmina Duivenvoorden; Darryl P Leong; Jehonathan H Pinthus
Journal:  Ther Adv Urol       Date:  2015-11-30

10.  The androgen metabolite, 5α-androstane-3β,17β-diol, decreases cytokine-induced cyclooxygenase-2, vascular cell adhesion molecule-1 expression, and P-glycoprotein expression in male human brain microvascular endothelial cells.

Authors:  Kristen L Zuloaga; Sibyl N Swift; Rayna J Gonzales; T John Wu; Robert J Handa
Journal:  Endocrinology       Date:  2012-11-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.